Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003363952 | SCV004071615 | uncertain significance | Inborn genetic diseases | 2023-07-19 | criteria provided, single submitter | clinical testing | The c.6444C>G (p.N2148K) alteration is located in exon 42 (coding exon 42) of the CUBN gene. This alteration results from a C to G substitution at nucleotide position 6444, causing the asparagine (N) at amino acid position 2148 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005036759 | SCV005673506 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2024-06-20 | criteria provided, single submitter | clinical testing |